AG

Apra Goyal

Active Director Director DIN 07544070
DIN 07544070 First appointment Jun 2016 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2016
Shareholding value •••• Premium profile

About Apra Goyal

Data last updated:

Apra Goyal is a Director at Meditrox Pharmaceuticals Private Limited (since 2016). The company operates in Chemicals. Meditrox Pharmaceuticals Private Limited reported revenue of ₹12.4 Lakh (FY 2020).

DIN 07544070
Primary Designation Director
Industry Chemicals
First Appointment 27 Jun 2016
Oldest Company Age 10 yrs
Largest company Meditrox Pharmaceuticals Private Limited · ₹12.4 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jun 20162016₹12.4 Lakh (FY 2020)Active

Board colleagues of Apra Goyal

NameDINCompanyDesignation
Vikas Kumar Goyal07544124Meditrox Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Meditrox Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Apra Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Apra Goyal

Apra Goyal currently holds 1 directorship: Meditrox Pharmaceuticals Private Limited (Director, since 27 Jun 2016, revenue ₹12.4 Lakh (FY 2020)).

Apra Goyal was first appointed on 27 Jun 2016 as Director at Meditrox Pharmaceuticals Private Limited.

The current boards of Apra Goyal's companies include Vikas Kumar Goyal (Meditrox Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available